BioDelivery Sciences International Revenue and Competitors

Claim your profile



Total Funding



Estimated Revenue & Valuation

  • BioDelivery Sciences International's estimated annual revenue is currently $165.7M per year.(i)
  • BioDelivery Sciences International received $50.0M in venture funding in May 2018.
  • BioDelivery Sciences International's estimated revenue per employee is $767,222
  • BioDelivery Sciences International's total funding is $250.7M.
  • BioDelivery Sciences International's current valuation is $302.3M. (January 2022)

Employee Data

  • BioDelivery Sciences International has 216 Employees.(i)
  • BioDelivery Sciences International grew their employee count by 14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

BioDelivery Sciences ("BDSI"®) is a specialty pharmaceutical company with a focus in the areas of pain management and addiction medicine. We are utilizing our novel and proprietary BioErodible MucoAdhesive (BEMA®) and other drug delivery technologies to develop and commercialize, either on our own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





BioDelivery Sciences International News

2022-04-17 - BioDelivery Sciences International (NASDAQ:BDSI) Coverage ...

BioDelivery Sciences International (NASDAQ:BDSI) Coverage Initiated by Analysts at Posted by admin on Apr 25th, 2022.

2022-04-13 - Begins Coverage on BioDelivery Sciences ...

Northland Securities cut BioDelivery Sciences International from an “outperform” rating to a “market perform” rating in a research note on...

2022-04-06 - Brokerages Set BioDelivery Sciences International, Inc ...

Brokerages Set BioDelivery Sciences International, Inc. (NASDAQ:BDSI) Target Price at $5.93. Posted by admin on Apr 11th, 2022.

2019-09-08 - BioDelivery Sciences Reports Strong Second Quarter 2019 ...

08, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

BioDelivery Sciences International Funding

DateAmountRoundLead InvestorsReference
2002-07-09$9.4MPublic OfferingArticle
2005-07-19$7.0MUndisclosedClinical Development Capital LArticle
2006-02-17$7.0MUndisclosedCDC IV LLCArticle
2012-11-29$40.0MUndisclosedWilliam Blair & Company L L CArticle
2015-06-02$20.7MUndisclosedMidCap FinancialArticle
2017-02-24$75.0MUndisclosedCRG LP,Article
2018-05-18$50.0MUndisclosedWilliam Blair & Company, L.L.C.Article